SMAD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.26898491714655E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.53829999638822E-08 |
Normal-vs-Stage2 |
4.62700000536387E-08 |
Normal-vs-Stage3 |
4.44089209850063E-16 |
Normal-vs-Stage4 |
1.76070269475304E-12 |
Stage1-vs-Stage2 |
1.271630E-01 |
Stage1-vs-Stage3 |
1.50519999999599E-05 |
Stage1-vs-Stage4 |
1.002610E-04 |
Stage2-vs-Stage3 |
8.746200E-02 |
Stage2-vs-Stage4 |
1.043800E-01 |
Stage3-vs-Stage4 |
9.208400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.12518891373747E-12 |
Normal-vs-AfricanAmerican |
2.61640042964473E-10 |
Normal-vs-Asian |
7.482000E-02 |
Caucasian-vs-AfricanAmerican |
8.894200E-02 |
Caucasian-vs-Asian |
4.544600E-01 |
AfricanAmerican-vs-Asian |
2.062800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.39617223232835E-12 |
Normal-vs-Female |
4.27158308724529E-12 |
Male-vs-Female |
7.824000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.035300E-04 |
Normal-vs-Age(41-60Yrs) |
3.18760018380715E-10 |
Normal-vs-Age(61-80Yrs) |
1.85362836191416E-12 |
Normal-vs-Age(81-100Yrs) |
1.50480000016273E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.941400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.876000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.225400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.244400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.370360E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.961000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.710400E-02 |
Normal-vs-Grade 2 |
4.56809999827001E-08 |
Normal-vs-Grade 3 |
1.6251444634463E-12 |
Normal-vs-Grade 4 |
2.49522624784504E-12 |
Grade 1-vs-Grade 2 |
3.182000E-01 |
Grade 1-vs-Grade 3 |
1.451520E-02 |
Grade 1-vs-Grade 4 |
8.296900E-03 |
Grade 2-vs-Grade 3 |
1.395860E-04 |
Grade 2-vs-Grade 4 |
1.386270E-04 |
Grade 3-vs-Grade 4 |
2.217800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.60599999965427E-08 |
Normal-vs-ccB subtype |
2.41510000886791E-09 |
ccA subtype-vs-ccB subtype |
4.700400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.76514358685154E-12 |
Normal-vs-N1 |
2.520000E-02 |
N0-vs-N1 |
7.256200E-01 |
|
|